GeneDx Holdings Corp. 8-K Report: Key Insights on Stock & Warrants - February 2025
Based on the provided section of the financial report, here are the key insights and important information extracted:
- Company Identification:
- Name: GeneDx Holdings Corp.
- CIK: 0001818331
- IRS Employer Identification Number: 85-1966622
- Address: 333 Ludlow Street, North Tower, 6th Floor, Stamford, CT 06902
- Phone: 888-729-1206
- Filing Type:
- Form: 8-K
- Filing Date: February 18, 2025
- Stock Information:
- Class of Stock: Class A common stock
- Par Value: $0.0001 per share
- Stock Ticker: WGS (NASDAQ)
- Warrants:
- Type: Warrants to purchase one share of Class A common stock
- Exercise Price: $379.50 per share
- Warrant Ticker: WGSWW (NASDAQ)
- Segments:
- The report indicates classifications under the US GAAP for Common Class A and Warrants.
- Reporting Period:
- The reporting date for the information is February 18, 2025.
Summary of Insights:
- GeneDx Holdings Corp. is a publicly traded company listed on NASDAQ under the ticker WGS. The report details the structure of its stock and warrants, highlighting a significant exercise price for its warrants, which may indicate a strategic pricing decision. The filing is categorized as an 8-K, which typically conveys important events or changes in the company. This document is crucial for investors and analysts monitoring the company's financial activities and stock performance.